Covid vaccination guidance – April 2021
New guidance issued over the last month largely relates to changes in advice around the use of the AstraZeneca vaccine, and licensing of the Moderna vaccine.
AstraZeneca
Lots of guidance relating to the AstraZeneca vaccine has been issued or updated in April, following concerns about the risk of blood clots and subsequent MHRA advice on this risk.
- Patient information leaflet, updated 15 April 2021.
- Healthcare professional information leaflet, updated 15 April 2021.
- Conditions of Authorisation, updated 15 April 2021.
- Summary of the Public Assessment Report, updated 15 April 2021.
- Information for healthcare professionals on blood clotting following Covid-19 vaccination, updated 9 April 2021.
- MHRA confirms that people should continue to receive the Covid-19 vaccine AstraZeneca, updated 7 April 2021.
- MHRA issues new advice, concluding a possible link between Covid-19 Vaccine AstraZeneca and extremely rare, unlikely to occur blood clots, published 7 April.
Moderna
The Moderna vaccine has now been approved for use and is currently being provided at three sites in London. If and when it is made widely available to GP run sites, we will provide further updates.
- Patient information leaflet, updated 19 April 2021.
- Patient Group Direction, updated 19 April 2021.
- Regulatory approval documents, updated 19 April 2021.
- National protocol, updated 8 April 2021.
- Letter from the JCVI on use of the Moderna vaccine in the Covid-19 immunisation programme, published 7 April 2021.
Provider Development Masterclasses (31 Mar 2016)
This series of day-long masterclasses aims to equip participants with relevant, practical business skills and knowledge that they can take back and use in their localities. Topics have been selected...RCGP guide to supporting information for appraisal and revalidation (30 Mar 2016)
The RCGP has approved a new guide to supporting information for appraisal and revalidation (March 2016) that aims to reduce inconsistencies in interpretation and streamline the process of providing...London GP Registration for Offenders (30 Mar 2016)
Londonwide LMCs welcomes the London GP Registration for Offenders initiative, it helps practices deal with the needs of an often vulnerable and challenging group of patients. Offenders have exactly the same rights...Patient online access for children aged 11-16 years (24 Mar 2016)
NHS England (NHSE) and the Royal College of General Practitioners (RCGP) have produced some helpful guidance about proxy access regarding Patient Online. The full guidance is available here and...Budget 2016 (17 Mar 2016)
Budget 2016 was, on the whole, fairly innocuous for health professionals. There were very few health-specific announcements (some money for children’s hospitals outside London) and a couple of measures that...New Housing Application letter and poster (17 Mar 2016)
Our new waiting room poster and template practice letter will help practice staff manage requests for letters supporting housing applications.Patient Online detailed coded record (DCR) deadline is 31 March 2016 (16 Mar 2016)
This month sees the deadline for enabling online access to patients’ detailed coded record (DCR). Practices have until 31 March 2016 to switch this on. The latest figures we...PMS contract reviews update (16 Mar 2016)
We recently issued our third PMS (Personal Medical Services) bulletin on the reviews taking place across London. Our bulletins are designed to bring you the current PMS contract review information...New Men B immunisation advice (16 Mar 2016)
Following recent high profile stories about child deaths from meningitis B, Public Health England has issued further advice: Men B immunisation programme Following recent media coverage about the death of...Guidance
We provide expert guidance for practices in our guidance section, as well as an archive of other materials you may find useful.
GP Support
Contact our GP Support team if you need help or advice.
The team provide professional and pastoral support to GPs and practice teams on a broad range of issues.